Back
Rayonier, Inc. 10K Form
Sell
44
RYN
Rayonier, Inc.
Last Price:
$23.04
Seasonality Move:
2.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-03 | 10Q | RYN/Rayonier, Inc. Quarterly |
| 2023-08-04 | 10Q | RYN/Rayonier, Inc. Quarterly |
| 2023-05-05 | 10Q | RYN/Rayonier, Inc. Quarterly |
| 2022-11-04 | 10Q | RYN/Rayonier, Inc. Quarterly |
| 2022-08-05 | 10Q | RYN/Rayonier, Inc. Quarterly |
| 2022-05-06 | 10Q | RYN/Rayonier, Inc. Quarterly |
Receive RYN News And Ratings
See the #1 stock for the next 7 days that we like better than RYN
RYN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $96.5M |
| Price / Cash Flow: | 16.18 |
| Annual Sales: | $14.88 |
| Price / Book: | 1.54 |
Profitability
| EPS (TTM): | 2.42770 |
|---|---|
| Net Income (TTM): | $785.5M |
| Gross Margin: | $479.3M |
| Return on Equity: | 38.93% |
| Return on Assets: | 22.69% |
Rayonier, Inc. Earnings Forecast
Key Rayonier, Inc. Financial Ratios
-
The Gross Profit Margin over the past 33 years for RYN is 37.95%.
-
The Selling, General & Administrative Expenses for RYN have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 2.31% of Operating Income.
-
The Net Earning history of RYN is 29.21% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 16 years.
Rayonier, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Specialized REITs |
| Sector: | Real Estate |
| Current Symbol: | RYN |
| CUSIP: | 754907 |
| Website: | rayonier.com |
Debt
| Debt-to-Equity Ratio: | 0.46 |
|---|---|
| Current Ratio: | 3.27 |
| Quick Ratio: | 3.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.62 |
|---|---|
| Forward P/E Ratio: | 46.24 |
RYN Technical Analysis vs Fundamental Analysis
Sell
44
Rayonier, Inc. (RYN)
is a Sell
Is Rayonier, Inc. a Buy or a Sell?
-
Rayonier, Inc. stock is rated a SellThe current Rayonier, Inc. [RYN] share price is $23.03. The Score for RYN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.